U.S. flag

An official website of the United States government

NM_152468.5(TMC8):c.1664+1G>A AND Epidermodysplasia verruciformis

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Apr 24, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003761153.1

Allele description [Variation Report for NM_152468.5(TMC8):c.1664+1G>A]

NM_152468.5(TMC8):c.1664+1G>A

Gene:
TMC8:transmembrane channel like 8 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q25.3
Genomic location:
Preferred name:
NM_152468.5(TMC8):c.1664+1G>A
HGVS:
  • NC_000017.11:g.78138480G>A
  • NG_007881.1:g.12703G>A
  • NM_152468.5:c.1664+1G>AMANE SELECT
  • LRG_119:g.12703G>A
  • NC_000017.10:g.76134561G>A
Molecular consequence:
  • NM_152468.5:c.1664+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Epidermodysplasia verruciformis
Identifiers:
MONDO: MONDO:0009176; MedGen: C0014522; OMIM: PS226400

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004561449Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Likely pathogenic
(Apr 24, 2023) 		germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

PubMed [citation]
PMID:
16199547
PMCID:
PMC1735933

Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.

Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M.

Nat Genet. 2002 Dec;32(4):579-81. Epub 2002 Nov 11.

PubMed [citation]
PMID:
12426567
See all PubMed Citations (4)

Details of each submission

From Invitae, SCV004561449.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant has not been reported in the literature in individuals affected with TMC8-related conditions. This variant is present in population databases (rs761524773, gnomAD 0.006%). This sequence change affects a donor splice site in intron 13 of the TMC8 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in TMC8 are known to be pathogenic (PMID: 12426567, 22158547).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024